This longitudinal twin study was designed to assess the heritability of bone loss in peri-and post-menopausal women. A sample of 724 female twins was studied. Baseline and repeat BMD measurements were performed. Results of genetic model-fitting analysis indicated genetic effects on bone loss account for around 40% of the between individual variation in bone loss at the lumbar spine, forearm and whole body.
Introduction
Osteoporosis is a common multifactorial disorder of reduced bone mass associated with micro-architectural deterioration of bone tissue leading to bone loss and increased bone fragility. The major consequence of bone loss is fracture. Typical osteoporotic fractures involve the proximal femur, thoraco-lumbar vertebral bodies and distal forearm, although many bones may be affected (1) (2) (3) (4) .
Low bone mineral density (BMD) is considered the hallmark of osteoporosis. Bone density measurements are valuable predictors of the risk of low-trauma fractures (5) . Bone loss is highly variable among individuals, with the typical standard deviation being between 2 and 3-fold higher than the mean rate of loss (6) (7) (8) . BMD at any given age is determined by the relative contributions of peak bone mass achieved and subsequent bone loss. It has been suggested that the relative contributions of peak bone mass and bone loss to BMD at age 70 are equal (9) . This implies that BMD in older women is significantly influenced by the rate of bone loss and bone turnover with advancing age. In support of this hypothesis, a cross-sectional twin study specifically selected for older female subjects (mean age 68 years) estimated additive genetic effects accounted for 75% of residual variation in spine and hip BMD after adjusting for environmental factors like smoking and alcohol intake (10) .
While the heritability of peak BMD is well documented in many family (11) (12) (13) (14) (15) (16) (17) (18) (19) and twin (20) (21) (22) (23) (24) (25) (26) studies, there is no clear evidence that the variation of bone loss is under genetic regulation (27) . A number of studies have attempted to dissect the genetic effect on rate of bone loss (28) (29) (30) . Only a few prospective studies on heritability of bone loss have been reported in humans (17, (31) (32) (33) (34) . No evidence of a genetic component to loss of BMD at the midshaft of the radius was found by Christian and colleagues in 25 MZ and 21 DZ older twin men (mean age 63 years) followed over a 16-yr period (31) . However, although the length of the study period was sufficient to detect significant bone loss, the sample size was small and the skeletal site measured is not a typical site of osteoporotic fracture in men or women. Moreover, in a study of older female twins there was no significant heritability of BMD at the distal forearm, suggesting that environment could be more powerful than genetic effects at this site with ageing (10) . Indeed, although the study of Christian found significant within-pair correlations for both identical (monozygotic or MZ) and non-identical (dizygotic or DZ) twins at the mid-shaft of the radius (intra-class correlations of 0.62 and 0.48 respectively), bone loss correlated with environmental factors such as smoking and alcohol intake and, after adjustment for these covariates, it was concluded that changes in bone density were more influenced by factors common within twin pairs such as common environmental influences rather than genetic factors (31) . There were other limitations to this study apart from the small sample size. Although the period of follow-up was long (16 years) , bone loss at the mid-shaft site was low (0.45% per year) with an overall loss of 6.9%, one half the rate reported in postmenopausal women at the same site (35) . In contrast, another small twin study observed genetic influences on change in BMD at the spine and hip in 21
MZ and 19 DZ twins measured over a mean three year period (33) . However, the period of study was relatively short, ranging from only 1-5 years, the subjects were a mixture of men, premenopausal and postmenopausal women who were largely not losing bone, and the age range was wide, extending from 25-65 years.
Thus, there are no current studies in the literature that adequately address the important question of whether the rate of bone loss is heritable at skeletal sites where osteoporotic fractures are common. The present study was designed to assess the heritability of bone loss in peri-and post-menopausal women, an age group in which bone loss is more readily measured.
Materials and methods

Subjects
Study subjects were female twin pairs with multiple visits, recruited as part of the (36) .
DNA fingerprinting was used to determine zygosity in twin pairs in which their zygosity was either unknown or disputed.
Bone Mineral Density Measurements
Baseline characteristics included age, height (m), weight (kg), BMI (Wt/Ht 2 ), and menopausal status for women. Lumbar spine (L1-L4), and hip were scanned by fan beam dual-energy X-ray absorptiometry (DEXA) machine (QDR 4500W or QDR 1000W, Hologic, Waltham, MA. USA). Twins within each pair were always scanned using the same densitometer. Bone mineral density (BMD) of lumbar spine, total hip, forearm and whole body were obtained from DEXA scans using standard protocols as previously described (37, 38) . Change in BMD (BMD) was expressed as percent gain or loss per year.
Statistical Analysis
Twin resemblance for a variable trait was assessed for MZ and DZ twin pairs separately by intra-class correlation analysis. In this method, the total variation (about the mean) of a trait was partitioned into two sources: between-pairs (B) and within-pairs (W).
The correlation was estimated as the difference between the two sources over their sum, i.e., (B-W)(B+W). The test for significant difference between the coefficients of MZ and DZ was based on the modified Fisher's z-transformation procedure (39) .
To estimate the heritability (proportion of variance of a trait attributable to genetic factors), we analysed the data according to the classical twin model (40) . In this model, the variance of a variable trait is partitioned into genetic and environmental components. The and e, respectively, which are equivalent to the standardized regression coefficients ( Figure   1 ). The amount of variance due to each source is the square of these parameters. To estimate a, d, c and e, for each variable trait, the data were summarized into 2 x 2 variancecovariance matrices. The matrices were then subject to analysis specified by five possible models incorporating different combinations of these factors, namely, E, CE, AE, ACE, and ADE. The maximum likelihood method was used to estimate model parameters. Selection of the best model was based on the difference between likelihood ratio chi-square goodnessof-fit tests. The index of heritability was obtained as the square of the parameter a from the most parsimonious model. Modelling was performed with adjustment for HRT use as well as a separate analysis excluding these subjects.
Results
The characteristics of the 724 peri-and postmenopausal female twins who participated in the study are presented in Tables 1 and 2 . There were 177 MZ and 185 DZ pairs. There were no significant differences between MZ and DZ twins in age, baseline BMD or dietary calcium intake or exercise (data not shown). There were significant differences in height and body mass index which were adjusted for in the analysis. The age of the twins ranged from 45 to 82 years at the initial visit (mean age 56. The results of the twin model analyses are presented in Table 3 . The maximum likelihood method was used to estimate model parameters. Selection of the best model was based on the difference between likelihood ratio chi-square goodness-of-fit tests. For lumbar spine, total forearm and whole body, AE models gave the best fit. The indices of heritability (A) were 38%, 49% and 44% for annual changes in lumbar spine, total forearm and whole body BMD, respectively when all twins were included. Adjustment for hormone therapy use did not significantly alter these results (Table 3) . When HRT users were excluded from the analysis, only lumbar spine heritability remained significant but the power was reduced at the forearm and whole body sites in this analysis.
Discussion
The results of the present study suggest that although genetic effects on bone loss with ageing are less pronounced than those on peak bone mass, they still account for around 40% of the between individual variation in bone loss at the lumbar spine, forearm and whole body in peri and postmenopausal women.
Susceptibility to osteoporosis is largely genetically determined, and it is likely that many genes are involved, each having a small effect (41) . Bone density after young adulthood is determined by peak bone mass and subsequent bone loss (9) . Cross-sectional studies in twins (20) (21) (22) (23) and families (11) (12) (13) (14) (15) (16) 18) have shown that peak bone mass is largely influenced by genetic factors . A cross sectional design however cannot directly assess the magnitude of bone loss heritability. Although bone density may be affected by many genes at different skeletal sites and in different age groups, it is likely that the magnitude of individual genetic effects differs in different populations and in different environmental settings (22) . The San Antonio Family osteoporosis study on Mexican American extended families showed similar results on heritability of bone loss to ours (17) . Our study is the first large longitudinal twin genetic epidemiological study to directly quantify the genetic versus environmental components of bone loss variance in peri-and postmenopausal women.
Previous twin studies that have measured longitudinal changes in BMD were much smaller studies in men or younger subjects and the findings were not consistent (31) (32) (33) . A longitudinal study of sisters did find a significant genetic influence on change in femoral neck BMD (34) , but the study subjects were premenopausal (mean age 35.3 years) and it was unclear whether this effect persists across the menopause. Our findings in the total hip and femoral neck sites suggest it does not. Greater environmental effects at the hip may decrease the power to show genetic effects at that site. Our study has several strengths and limitations. The mean annual BMD loss in our study was lower than reported in some previous longitudinal studies (6) (7) (8) (42) (43) (44) . However these high rates of bone loss have mainly been observed in the elderly and our observed rates of loss are similar to other studies of peri-and postmenopausal women (44) (45) (46) . Moreover, rates of bone loss may be influenced by multiple factors including age, body composition and environmental factors. A large percentage of our twins had exposure of greater than 12 months to estrogen therapy but adjusting for hormone use did not affect the results. Moreover, when the analysis was confined to the twins who had never had HRT, a significant effect of heritability on bone loss was still evident in the lumbar spine. Because baseline BMD is used to calculate rate of loss, bone loss rate can never be truly independent of baseline BMD (27) . Although this phenomenon may account for the observation of faster bone loss in women with higher BMD, the effect of baseline BMD appears to be small (47) .
In a re-analysis, controlling for baseline BMD, of 75 women followed for 9.5 years, it was estimated 67% of postmenopausal variation was attributable to premenopausal BMD, whereas 29% was attributable to the bone loss rate (27) . Our figure of around 40% heritability in bone loss would not be inconsistent with that analysis. Our study sample is 10 fold larger than previous longitudinal twin studies and of satisfactory duration (mean 5 years follow-up), which should diminish the effects of measurement error related to small changes in BMD over time. Inferring a genetic aetiology by contrasting MZ and DZ twins rests on the assumption that the twins share a common family environment to the same extent. This assumption may not hold for a number of environmental variables that might affect bone loss such as exercise and smoking (48) . However the effects of these covariates are likely to be modest.
In conclusion, our data suggest that although genetic effects on bone loss with ageing are less pronounced than on peak bone mass, they account for around 40% of the between-individuals variation in bone loss at the lumbar spine, forearm and whole body in pre-and post-menopausal women. These findings provide a rational basis for the identification of genes that are involved in the regulation of bone loss. Table 2 . Standardised parameter estimates for HRT-user inclusive and exclusive models. 
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